Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 3/20 | 0.37 |
| ▸ | MAOA | P21397 | 2/20 | 0.37 |
| ▸ | AR | P10275 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | HPGD | P15428 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | ACHE | P22303 | 2/20 | 0.35 |
| ▸ | BCHE | P06276 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | PPARA | Q07869 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18026503 | 0.86 | MAOA (0.49) | MAOBMAOAARKDM4EALDH1A1 | |
| SCHEMBL18026505 | 0.76 | CYP1A1 (0.49) | MAOBMAOAARKDM4EALDH1A1 | |
| SCHEMBL12617766 | 0.66 | CYP1A1 (0.60) | MAOBMAOAARKDM4EALDH1A1 | |
| SCHEMBL12617399 | 0.66 | MAOB (0.70) | MAOBMAOAARKDM4EALDH1A1 | |
| SCHEMBL14680977 | 0.64 | AR (0.59) | MAOBMAOAARKDM4EALDH1A1 | |
| SCHEMBL7915768 | 0.63 | ALDH1A1 (0.58) | MAOBMAOAARKDM4EALDH1A1 | |
| SCHEMBL22501611 | 0.63 | MAOB (0.68) | MAOBMAOAARKDM4EALDH1A1 | |
| SCHEMBL8834751 | 0.62 | MAOA (0.56) | MAOBMAOAARKDM4EALDH1A1 | |
| SCHEMBL8934483 | 0.62 | AR (0.61) | MAOBMAOAARKDM4EALDH1A1 | |
| SCHEMBL12617458 | 0.62 | MAOB (0.67) | MAOBMAOAARKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160243047-A1 | SURFACE FUNCTIONALIZED, HOST-GUEST POLYMER NANO-ASSEMBLIES AND METHODS THEREOF | UNIV MASSACHUSETTS (US) | 2016-08-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160243047-A1 | SURFACE FUNCTIONALIZED, HOST-GUEST POLYMER NANO-ASSEMBLIES AND METHODS THEREOF | MSN, CD44, EPHA2 | MAOB 1243/4885MAOA 725/4885AR 1038/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.